MYCN and neoplasm: In the following 20 years, several studies confirmed that deregulated c-MYC/MYCN expression collaborates with other genetic alterations to circumvent multiple intrinsic tumor-suppressing mechanisms (which inherently prevent MYC activation from initiating tumorigenesis) in order to start forming tumors in vivo.